Temat: "Astrocytoma" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma.
Autorzy:: Johns DA; School of Medicine, Deakin University, Geelong, Victoria, Australia.
Williams RJ; School of Medicine, Deakin University, Geelong, Victoria, Australia.; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.; The Graeme Clark Institute, The University of Melbourne, Melbourne, VIC, Australia.
Smith CM; School of Medicine, Deakin University, Geelong, Victoria, Australia.; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Nadaminti PP; School of Agriculture, Food and Ecosystem Sciences, Faculty of Science, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Samarasinghe RM; School of Medicine, Deakin University, Geelong, Victoria, Australia.; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1560.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Brain Neoplasms*/diagnosis
Brain Neoplasms*/genetics
Brain Neoplasms*/therapy
Astrocytoma*/genetics
Astrocytoma*/therapy
Astrocytoma*/pathology
Adult ; Humans ; Child ; Histones/genetics ; Histones/metabolism ; Epigenesis, Genetic/genetics ; Epigenomics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Exploring prognostic factors and treatment strategies for long-term survival in pleomorphic xanthoastrocytoma patients.
Autorzy:: Lee C; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Byeon Y; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim GJ; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Jeon J; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Hong CK; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim JH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim YH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Cho YH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Hong SH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Chong SJ; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Song SW; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 26; Vol. 14 (1), pp. 4615. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/pathology
Astrocytoma*/diagnostic imaging
Astrocytoma*/therapy
Astrocytoma*/pathology
Humans ; Prognosis ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Gene Expression of CSF3R /CD114 Is Associated with Poorer Patient Survival in Glioma.
Autorzy:: Bark SA; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Curitiba 80730-000, PR, Brazil.; The Center for Advanced Neurology and Neurosurgery (CEANNE), Porto Alegre 90560-010, RS, Brazil.
Dalmolin M; InovAI Lab, nPITI/IMD, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.; Bioinformatics Multidisciplinary Environment (BioME), Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
Malafaia O; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Curitiba 80730-000, PR, Brazil.
Roesler R; Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, RS, Brazil.
Fernandes MAC; InovAI Lab, nPITI/IMD, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.; Bioinformatics Multidisciplinary Environment (BioME), Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.; Department of Computer Engineering and Automation, Federal University of Rio Grande do Norte, Natal 59078-970, RN, Brazil.
Isolan GR; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Curitiba 80730-000, PR, Brazil.; The Center for Advanced Neurology and Neurosurgery (CEANNE), Porto Alegre 90560-010, RS, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, RS, Brazil.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 05; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Glioma*
Glioblastoma*/metabolism
Astrocytoma*/metabolism
Brain Neoplasms*/pathology
Central Nervous System Neoplasms*
Adult ; Child ; Humans ; Signal Transduction ; Gene Expression ; Receptors, Colony-Stimulating Factor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors.
Autorzy:: Dibdiakova K; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4D, 03601 Martin, Slovakia.; Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4C, 03601 Martin, Slovakia.
Majercikova Z; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4D, 03601 Martin, Slovakia.
Galanda T; Department of Neurosurgery, Roosevelt Hospital, Slovak Medical University, Nam. L. Svobodu 1, 97517 Banska Bystrica, Slovakia.
Richterova R; Clinic of Neurosurgery, Jessenius Faculty of Medicine in Martin, University Hospital in Martin, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.
Kolarovszki B; Clinic of Neurosurgery, Jessenius Faculty of Medicine in Martin, University Hospital in Martin, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.
Racay P; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4D, 03601 Martin, Slovakia.
Hatok J; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4D, 03601 Martin, Slovakia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 01; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*
Brain Neoplasms*
Astrocytoma*
Humans ; Matrix Metalloproteinase 2/metabolism ; Matrix Metalloproteinase 9/metabolism ; Tissue Inhibitor of Metalloproteinase-1/metabolism ; Tissue Inhibitor of Metalloproteinases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Clinical and molecular study of radiation-induced gliomas.
Autorzy:: Trkova K; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Sumerauer D; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Bubenikova A; Department of Neurosurgery, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Krskova L; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Vicha A; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Koblizek M; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Zamecnik J; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Jurasek B; Department of Radiology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Kyncl M; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Radiology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Malinova B; Department of Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Ondrova B; Proton Therapy Center Czech, Budínova 1a, 180 00, Prague, Czech Republic.
Jones DTW; Division of Pediatric Glioma Research, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sill M; Division of Pediatric Glioma Research, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Strnadova M; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Stolova L; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Misove A; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Benes V 3rd; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic.; Department of Neurosurgery, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic.
Zapotocky M; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic. .; Center for Pediatric Neuro-Oncology, University Hospital Motol, V Uvalu 84 , 15006, Prague 5, Czech Republic. .; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 15006, Prague 5, Czech Republic. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 3118. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Glioma*/genetics
Glioma*/radiotherapy
Brain Neoplasms*/genetics
Brain Neoplasms*/radiotherapy
Astrocytoma*/pathology
Humans ; Proto-Oncogene Proteins B-raf/genetics ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.
Autorzy:: Cockerell I; Department of Rare Disorders and Disabilities, National Centre for Rare Epilepsy-Related Disorders, Oslo University Hospital, Pb 4950, 0424, Nydalen, Oslo, Norway. .
Christensen J; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Neurology, Aarhus University Hospital, Affiliated Member of the European Reference Network EpiCARE, Aarhus, Denmark.
Hoei-Hansen CE; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.; Department of Paediatrics, University Hospital Rigshospitalet, Copenhagen, Denmark.
Holst L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Grenaa Frederiksen M; Department of Paediatrics, University Hospital Rigshospitalet, Copenhagen, Denmark.
Issa-Epe AI; Section of Abdominal Radiology, Department of Radiology, Oslo University Hospital, Oslo, Norway.
Nedregaard B; Section of Neuroradiology, Department of Radiology, Oslo University Hospital, Oslo, Norway.
Solhoff R; Department of Neurology, Sørlandet Hospital, Arendal, Norway.
Heimdal K; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Johannessen Landmark C; Department of Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.; The National Center for Epilepsy (SSE), Member of the ERN EpiCare, Oslo University Hospital, Oslo, Norway.; Section for Clinical Pharmacology, SSE, Department of Pharmacology, Oslo University Hospital, Oslo, Norway.
Lund C; Department of Rare Disorders and Disabilities, National Centre for Rare Epilepsy-Related Disorders, Oslo University Hospital, Pb 4950, 0424, Nydalen, Oslo, Norway.
Nærland T; K.G. Jebsen Center for Neurodevelopmental Disorders, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; NevSom, Department of Rare Disorders and Disabilities, Oslo University Hospital, Oslo, Norway.; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 Dec 02; Vol. 18 (1), pp. 377. Date of Electronic Publication: 2023 Dec 02.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Angiomyolipoma*/drug therapy
Antineoplastic Agents*/adverse effects
Astrocytoma*/chemically induced
Astrocytoma*/complications
Astrocytoma*/drug therapy
Epilepsy*/drug therapy
Kidney Neoplasms*/complications
Tuberous Sclerosis*/drug therapy
Tuberous Sclerosis*/complications
Adolescent ; Adult ; Child ; Child, Preschool ; Humans ; Infant ; Middle Aged ; Young Adult ; Everolimus/adverse effects ; Seizures/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
Autorzy:: Tateishi K; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan. .; Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University, Yokohama, Japan. .; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan. .
Miyake Y; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Nakamura T; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Iwashita H; Department of Pathology, Yokohama City University Hospital, Yokohama, Japan.; Department of Diagnostic Pathology, Yokohama City University Hospital, Yokohama, Japan.
Hayashi T; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Oshima A; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Honma H; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Hayashi H; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Sugino K; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.; Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University, Yokohama, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Kato M; Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University, Yokohama, Japan.; Neurosurgical-Oncology Laboratory, Yokohama City University, Yokohama, Japan.
Satomi K; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Fujii S; Department of Diagnostic Pathology, Yokohama City University Hospital, Yokohama, Japan.; Department of Molecular Pathology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Komori T; Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
Yamamoto T; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa, Yokohama, 2360004, Japan.
Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.; Translational-Neurooncology Laboratory, Brain Tumor Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Wakimoto H; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.; Translational-Neurooncology Laboratory, Brain Tumor Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Nov 27; Vol. 11 (1), pp. 186. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Astrocytoma*/genetics
Astrocytoma*/pathology
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Receptor, Platelet-Derived Growth Factor alpha*/genetics
Retinoblastoma Protein*/genetics
Animals ; Humans ; Mice ; Homozygote ; Isocitrate Dehydrogenase/genetics ; Mutation ; Sequence Deletion ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: A 3-Year-Old Girl with Brain Imaging Findings Suggesting Arachnoid Cyst, and Biopsy Diagnosis of Extra-Axial Multicystic Pilocytic Astrocytoma.
Autorzy:: AlMousa SS; Department of Radiology, College of Medicine King Faisal University, Al-Ahsa, Saudi Arabia.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Jan 21; Vol. 25, pp. e941990. Date of Electronic Publication: 2024 Jan 21.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Arachnoid Cysts*/diagnostic imaging
Arachnoid Cysts*/surgery
Astrocytoma*/diagnostic imaging
Astrocytoma*/surgery
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/surgery
Child, Preschool ; Female ; Humans ; Biopsy ; Magnetic Resonance Imaging ; Neuroimaging

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro.
Autorzy:: Sumorek-Wiadro J; Department of Functional Anatomy and Cytobiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland.
Zając A; Department of Functional Anatomy and Cytobiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland.
Skalicka-Woźniak K; Independent Laboratory of Natural Products Chemistry, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.
Rzeski W; Department of Functional Anatomy and Cytobiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland.; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-950 Lublin, Poland.
Jakubowicz-Gil J; Department of Functional Anatomy and Cytobiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 07; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 07.
Typ publikacji:: Journal Article
MeSH Terms:: Glioma*/drug therapy
Furocoumarins*/pharmacology
Glioblastoma*
Astrocytoma*
Chromones*
Morpholines*
Humans ; Sorafenib/pharmacology ; Phosphatidylinositol 3-Kinases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A novel BRAF::PTPRN2 fusion in meningioma: a case report.
Autorzy:: Sadagopan NS; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL, 60611, USA.
Nandoliya KR; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL, 60611, USA.
Youngblood MW; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL, 60611, USA.
Horbinski CM; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL, 60611, USA.; Department of Pathology, Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Ward 3-140, Chicago, IL, 60611, USA.
Ahrendsen JT; Department of Pathology, Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Ward 3-140, Chicago, IL, 60611, USA.
Magill ST; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL, 60611, USA. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Dec 08; Vol. 11 (1), pp. 194. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Meningeal Neoplasms*/diagnostic imaging
Meningeal Neoplasms*/genetics
Meningeal Neoplasms*/surgery
Meningioma*/diagnostic imaging
Meningioma*/genetics
Meningioma*/surgery
Oncogene Proteins, Fusion*/genetics
Oncogene Proteins, Fusion*/metabolism
Proto-Oncogene Proteins B-raf*/genetics
Proto-Oncogene Proteins B-raf*/metabolism
Adult ; Female ; Humans ; Receptor-Like Protein Tyrosine Phosphatases, Class 8

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas.
Autorzy:: Verissimo DCA; Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil.; Clinical Hospital of the Federal University of Paraná, Curitiba, Paraná, Brazil.
Camillo-Andrade AC; Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil.
Santos MDM; Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil.
Sprengel SL; Clinical Hospital of the Federal University of Paraná, Curitiba, Paraná, Brazil.
Zanine SC; Clinical Hospital of the Federal University of Paraná, Curitiba, Paraná, Brazil.
Borba LAB; Clinical Hospital of the Federal University of Paraná, Curitiba, Paraná, Brazil.
Carvalho PC; Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil.
da G Fischer JS; Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Nov 15; Vol. 18 (11), pp. e0290087. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/pathology
Astrocytoma*/pathology
Glioblastoma*/pathology
Humans ; Proteomics ; Signal Transduction ; Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Autorzy:: Rautajoki KJ; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland. .; Tampere Institute for Advanced Study, Tampere University, Tampere, Finland. .
Jaatinen S; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Hartewig A; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Tiihonen AM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Salonen I; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Valkonen M; Institute of Biomedicine, University of Turku, Turku, Finland.
Simola V; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Vuorinen EM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Kivinen A; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Rauhala MJ; Department of Neurosurgery, Tampere University Hospital and Tampere University, Tampere, Finland.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
Nurminen R; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Maass KK; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro Oncology, German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Lahtela SL; Department of Oncology, Tampere University Hospital and Tays Cancer Centre, Tampere, Finland.
Jukkola A; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Department of Oncology, Tampere University Hospital and Tays Cancer Centre, Tampere, Finland.
Yli-Harja O; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Institute for Systems Biology, Seattle, WA, USA.
Helén P; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro Oncology, German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Ruusuvuori P; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland.
Haapasalo J; Department of Neurosurgery, Tampere University Hospital and Tampere University, Tampere, Finland.; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland.
Zhang W; Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Haapasalo H; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland.
Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Nov 06; Vol. 11 (1), pp. 176. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain Neoplasms*/genetics
Glioma*/genetics
Astrocytoma*/genetics
Humans ; Retrospective Studies ; Mutation ; Temozolomide/therapeutic use ; Genomics ; Isocitrate Dehydrogenase/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
Autorzy:: Krolicki L; Nuclear Medicine Department, Medical University of Warsaw, 02-091 Warsaw, Poland.
Kunikowska J; Nuclear Medicine Department, Medical University of Warsaw, 02-091 Warsaw, Poland.
Cordier D; Neurosurgery Department, University Hospital Basel, 4031 Basel, Switzerland.
Slavova N; Department of Neurology, Inselspital, University Hospital Bern, 3010 Bern, Switzerland.
Koziara H; Department of Neurosurgery, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.
Bruchertseifer F; European Commission, Joint Research Centre (JRC), 76125 Karlsruhe, Germany.
Maecke HR; Nuclear Medicine and Radiochemistry, University Hospital Basel, 4031 Basel, Switzerland.
Morgenstern A; European Commission, Joint Research Centre (JRC), 76125 Karlsruhe, Germany.
Merlo A; Department of Neurosurgery, Bern and University of Basel, 4001 Basel, Switzerland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 28; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 28.
Typ publikacji:: Journal Article
MeSH Terms:: Oligodendroglioma*/drug therapy
Oligodendroglioma*/pathology
Glioma*/drug therapy
Glioma*/radiotherapy
Astrocytoma*/drug therapy
Astrocytoma*/pathology
Glioblastoma*
Brain Neoplasms*/drug therapy
Brain Neoplasms*/radiotherapy
Brain Neoplasms*/pathology
Humans ; Substance P

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Amide proton transfer imaging-arterial spin labeling mismatch: a new imaging biomarker for pilocytic astrocytoma.
Autorzy:: Rajendran A; Apollo Proton Cancer Centre, Chennai, India.
Natesan C; Apollo Proton Cancer Centre, Chennai, India.
Jawahar P; Apollo Proton Cancer Centre, Chennai, India.
Patil S; Apollo Proton Cancer Centre, Chennai, India.
Chilukuri S; Apollo Proton Cancer Centre, Chennai, India.
Ghosh S; Apollo Proton Cancer Centre, Chennai, India.
Kumar R; Apollo Proton Cancer Centre, Chennai, India.
Jalali R; Apollo Proton Cancer Centre, Chennai, India. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Sep 29; Vol. 13 (1), pp. 16377. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Astrocytoma*/diagnostic imaging
Astrocytoma*/pathology
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Humans ; Protons ; Spin Labels ; Amides ; Magnetic Resonance Imaging/methods ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Diencephalic Syndrome: Misleading Clinical Onset of Low-Grade Glioma.
Autorzy:: La Spina M; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Caruso M; Pediatric Endocrinology and Diabetology Center, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Gulizia C; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Comella M; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Soma R; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Meli M; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Samperi P; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Bertuna G; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Di Cataldo A; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Russo G; Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Sep 13; Vol. 30 (9), pp. 8401-8410. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:: Case Reports; Research Support, Non-U.S. Gov't
MeSH Terms:: Astrocytoma*/complications
Astrocytoma*/diagnosis
Astrocytoma*/drug therapy
Glioma*/complications
Glioma*/diagnosis
Humans ; Delayed Diagnosis/adverse effects ; Quality of Life ; Failure to Thrive/etiology ; Syndrome

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Molecular profiling of pre- and post-treatment pediatric high-grade astrocytomas reveals acquired increased tumor mutation burden in a subset of recurrences.
Autorzy:: Wood MD; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, L-113, Portland, OR, 97239, USA. .; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. .
Beadling C; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Neff T; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Moore S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
Harrington CA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.; Integrated Genomics Laboratory, Oregon Health & Science University, Portland, OR, USA.
Baird L; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.; Boston Children's Hospital, Boston, MA, USA.
Corless C; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, L-113, Portland, OR, 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Sep 05; Vol. 11 (1), pp. 143. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Astrocytoma*
Glioma*
Adult ; Humans ; Child ; Temozolomide ; Neoplasm Recurrence, Local ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Autorzy:: Chen W; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo S; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shi Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo X; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; China Anti-Cancer Association Specialty Committee of Glioma, Beijing, China.
Liu D; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xing H; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xia Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li J; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu J; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liang T; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang H; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Q; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jin S; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qu T; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li H; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang T; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang K; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Y; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; China Anti-Cancer Association Specialty Committee of Glioma, Beijing, China.
Ma W; Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; China Anti-Cancer Association Specialty Committee of Glioma, Beijing, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 18666-18678. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain Neoplasms*
Astrocytoma*/genetics
Central Nervous System Neoplasms*/genetics
Glioblastoma*
Humans ; N-Myc Proto-Oncogene Protein ; Isocitrate Dehydrogenase/genetics ; Mutation ; World Health Organization

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Optical Differentiation of Brain Tumors Based on Raman Spectroscopy and Cluster Analysis Methods.
Autorzy:: Ospanov A; Institute for Physics and Engineering in Biomedicine, National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.
Romanishkin I; Prokhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.
Savelieva T; Institute for Physics and Engineering in Biomedicine, National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.; Prokhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.
Kosyrkova A; Department of Cryopreservation and Molecular Genetic Analysis, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
Shugai S; Department of Cryopreservation and Molecular Genetic Analysis, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
Goryaynov S; Department of Cryopreservation and Molecular Genetic Analysis, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
Pavlova G; Department of Cryopreservation and Molecular Genetic Analysis, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.; Institute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, 117485 Moscow, Russia.
Pronin I; Department of Cryopreservation and Molecular Genetic Analysis, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
Loschenov V; Institute for Physics and Engineering in Biomedicine, National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.; Prokhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 22; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 22.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/pathology
Astrocytoma*
Glioblastoma*/pathology
Meningeal Neoplasms*
Humans ; Spectrum Analysis, Raman/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment.
Autorzy:: Cedergren Weber G; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Timpka J; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Rydelius A; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Bengzon J; Division of Neurosurgery, Department of Clinical Sciences, Kamprad laboratory, Lund University, Lund, Sweden.; Department of Neurosurgery, Skåne University Hospital, Lund, Sweden.
Odin P; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.; Pokaż więcej
Źródło:: Brain and behavior [Brain Behav] 2023 Aug; Vol. 13 (8), pp. e3151. Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Parkinsonian Disorders*/drug therapy
Parkinsonian Disorders*/complications
Brain Neoplasms*/complications
Brain Neoplasms*/drug therapy
Astrocytoma*/complications
Paraneoplastic Syndromes*/complications
Meningeal Neoplasms*/complications
Cysts*/complications
Humans ; Dopamine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Artificial Intelligence-Assisted Classification of Gliomas Using Whole Slide Images.
Autorzy:: Jose L; From the Computational NeuroSurgery Lab (Jose, Liu, Russo, Di Ieva), Macquarie University, Sydney, Australia.
Liu S; From the Computational NeuroSurgery Lab (Jose, Liu, Russo, Di Ieva), Macquarie University, Sydney, Australia.; Australian Institute of Health Innovation, Centre for Health Informatics (Liu), Macquarie University, Sydney, Australia.
Russo C; From the Computational NeuroSurgery Lab (Jose, Liu, Russo, Di Ieva), Macquarie University, Sydney, Australia.
Cong C; The School of Computer Science and Engineering, University of New South Wales, Sydney, Australia (Cong, Song).
Song Y; The School of Computer Science and Engineering, University of New South Wales, Sydney, Australia (Cong, Song).
Rodriguez M; Macquarie Medical School (Rodriguez), Macquarie University, Sydney, Australia.
Di Ieva A; From the Computational NeuroSurgery Lab (Jose, Liu, Russo, Di Ieva), Macquarie University, Sydney, Australia.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Aug 01; Vol. 147 (8), pp. 916-924.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/diagnostic imaging
Oligodendroglioma*/diagnostic imaging
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Glioma*/diagnostic imaging
Glioma*/genetics
Astrocytoma*/diagnostic imaging
Adult ; Humans ; Artificial Intelligence

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Astrocytoma"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język